Combining psychosocial treatment with pharmacotherapy for alcohol dependence

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6 SUPPL. 1, 2006, Pages

  Weiss, Roger D ^a,b   Kueppenbender, Karsten D ^c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Cambridge Health Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM; NALTREXONE;

ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; HUMAN; MARITAL THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; SOCIAL SUPPORT;

ALCOHOL DETERRENTS; ALCOHOLICS ANONYMOUS; ALCOHOLISM; COMBINED MODALITY THERAPY; HUMANS; PATIENT COMPLIANCE; SOCIAL SUPPORT;

EID: 33751086170     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000248604.58305.b3     Document Type: Conference Paper

References (42)

1. Nowinski J, Baker S, Carroll KM. Twelve Step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Project MATCH Monograph Series, Vol 2. Rockville, MD: NIAAA; 1995.
2. Miller WR, Zweben A, DiClemente CC, et al. Motivational Enhancement Therapy Manual, Vol 2. Rockville, MD: NIAAA; 1994.
3. Kadden R, Carroll KM, Donovan D, et al. Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals With Alcohol Abuse and Dependence. Vol 3. Rockville, MD: NIAAA; 1995.
4. O'Farrell TJ, Allen JP, Litten RZ. Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA Res Monogr. 1995;150:65-91.
5. Miller WR. Combined Behavioral Intervention Manual: A Clinical Research Guide for Therapists Treating People With Alcohol Abuse and Dependence. Vol 1. Rockville, MD: NIAAA; 2004.
6. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7-29.
7. Monti P, Abrams D, Kadden R, et al. Treating Alcohol Dependence: A Coping Skills Training Guide. New York, NY: Guilford Press; 1989.
8. Weiss RD, Jaffee WB, de Menil VP, et al. Group therapy for substance use disorders: what do we know? Harv Rev Psychiatry. 2004;12:339-350.
9. O'Farrell TJ, Fals-Stewart W. Behavioral couples therapy for alcoholism and drug abuse. J Subst Abuse Treat. 2000;18:51-54.
10. Morgenstern J, Labouvie E, McCrady BS, et al. Affiliation with Alcoholics Anonymous after treatment: a study of its therapeutic effects and mechanisms of action. J Consult Clin Psychol. 1997;65:768-777.
11. Humphreys K, Moos RH. Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatr Serv. 1996;47:709-713.
12. Rychtarik RG, Connors GJ, Dermen KH, et al. Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes. J Stud Alcohol. 2000;61:134-138.
13. Alcoholics Anonymous. The AA Member, Medication, and Other Drugs. New York, NY: Alcoholic Anonymous World Services; 1984. Brochure.
14. Mason BJ, Goodman AM. Brief Intervention and Medication Compliance Procedures: Therapist's Manual. New York, NY: Lipha Pharmaceuticals Inc; 1997.
15. Pettinati HM, Weiss RD, Miller WR, et al. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of Treatment of Alcohol Dependence. Vol 2. Bethesda, MD: NIAAA; 2004.
16. Volpicelli J, Pettinati HM, McLellan AT, et al. Combining Medication and Psychosocial Treatments for Addictions. New York, NY: Guilford Press; 2001.
17. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003-2017.
18. Volpicelli JR, Rhines KC, Rhines JS, et al. Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry. 1997;54:737-742.
19. Pettinati HM, Volpicelli JR, Pierce JD Jr, et al. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000;19:71-83.
20. Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA. 1986;256:1449-1455.
21. Magura S, Laudet AB, Mahmood D, et al. Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv. 2002;53:310-316.
22. Kamali M, Kelly L, Gervin M, et al. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv. 2001;52:161-163, 166.
23. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196-201.
24. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419.
25. O'Farrell TJ, Cutter HSG, Floyd FJ. Evaluating behavioral marital therapy for male alcoholics: effects on marital adjustment and communication from before to after treatment. Behav Ther. 1985;16:147-167.
26. O'Farrell TJ, Cutter HSG, Choquette KA, et al. Behavioral marital therapy for male alcoholics: marital and drinking adjustment during the two years after treatment. Behav Ther. 1992;23:529-549.
27. O'Farrell TJ, Bayog RD. Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking. J Subst Abuse Treat. 1986;3:1-8.
28. O'Farrell TJ, Choquette KA, Cutter HS. Couples relapse prevention sessions after behavioral marital therapy for male alcoholics: outcomes during the three years after starting treatment. J Stud Alcohol. 1998;59:357-370.
29. O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992;49:881-887.
30. O'Malley SS, Jaffe AJ, Chang G, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry. 1996;53:217-224.
31. Heinala P, Alho H, Kiianmaa K, et al. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2001;21:287-292.
32. Krystal JH, Cramer JA, Krol WF, et al. Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001;345:1734-1739.
33. Anton RF, Moak DH, Latham P, et al. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005;25:349-357.
34. O'Brien CP, Volpicelli LA, Volpicelli JR. Naltrexone in the treatment of alcoholism: a clinical review. Alcohol. 1996;13:35-39.
35. Soyka M, Preuss U, Schuetz C. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study. Drugs R D. 2002;3:1-12.
36. De Wildt WA, Schippers GM, Van Den Brink W, et al. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems? Alcohol Alcohol. 2002;37:375-382.
37. Miller WR, Rollnick S. Motivational Interviewing. Preparing People to Change Addictive Behavior. New York, NY: Guilford Press; 1991.
38. Kadden R, Carroll KM, Donovan D, et al. Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Rockville, MD: NIAAA; 1992.
39. Pelc I, Ansoms C, Lehert P, et al. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcohol Clin Exp Res. 2002;26:1529-1538.
40. Feeney GF, Young RM, Connor JP, et al. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved? Aust N Z J Psychiatry. 2002;36:622-628.
41. Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2003;60:92-99.
42. O'Malley SS, Rounsaville BJ, Farren C, et al. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. Arch Intern Med. 2003;163:1695-1704.